XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Revenue $ 1,027 $ 503 $ 2,657 $ 3,123
Operating expenses:        
Cost of goods sold (exclusive of depreciation and amortization) 3,232 2,830 9,397 8,868
Research and development 5,007 4,567 14,579 12,725
Selling, general and administrative 6,152 10,152 18,722 29,874
Depreciation and amortization 1,256 891 3,559 2,657
Total operating expenses 15,647 18,440 46,257 54,124
Operating loss (14,620) (17,937) (43,600) (51,001)
Other income (expense):        
Interest income (expense) (1,740) 336 (1,614) 445
Change in fair value of warrants (6,737) (962) (9,800) 23,188
Other loss (99) (152) (166) (205)
Loss before income taxes (23,196) (18,715) (55,180) (27,573)
Provision for income taxes 24 15 159 41
Net loss (23,220) (18,730) (55,339) (27,614)
Foreign currency translation adjustment (670) (2) (218) (24)
Comprehensive loss (23,890) (18,732) (55,557) (27,638)
Net loss (23,220) (18,730) (55,339) (27,614)
Net loss attributable to common stockholders $ (23,220) $ (18,730) $ (55,339) $ (27,614)
Weighted average of shares outstanding – basic (in shares) 108,045 101,397 107,504 98,513
Weighted average of shares outstanding – diluted (in shares) 108,045 101,397 107,504 98,513
Net loss attributable to common stockholders per share - basic (in dollars per share) $ (0.21) $ (0.18) $ (0.51) $ (0.28)
Net loss attributable to common stockholders per share - diluted (in dollars per share) $ (0.21) $ (0.18) $ (0.51) $ (0.28)